Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 1154-1164

  Zhang, Yan ^a   Liu, Shuxun ^a   Yu, Yizhi ^a   Zhang, Ting ^a   Liu, Juan ^a   Shen, Qian ^a   Cao, Xuetao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DCs; Fc RIIb; IC; Immunotherapy; SLE

Indexed keywords

ADENOVIRUS VECTOR; FC RECEPTOR IIB; IMMUNOGLOBULIN; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL MATURATION; DENDRITIC CELL; DOWN REGULATION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE PROGRESSION; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; RECEPTORS, IGG; TOLL-LIKE RECEPTORS;

EID: 79953047121     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040767     Document Type: Article

References (35)

1. Shortman, K. and Liu, Y. J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151-161.
2. Zhang, M., Tang, H., Guo, Z., An, H., Zhu, X., Song, W., Guo, J. X. et al., Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat. Immunol. 2004. 5: 1124-1133.
3. Selenko-Gebauer, N., Majdic, O., Szekeres, A., Höfler, G., Guthann, E., Korthäuer, U., Zlabinger, G. et al., B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 2003. 170: 3637-3644.
4. Oldenhove, G., de Heusch, M., Urbain-Vansanten, G., Urbain, J., Maliszewski, C., Leo, O. and Moser, M., CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 2003. 198: 259-266.
5. Pulendran, B., Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol. Res. 2004. 29: 187-196.
6. Zheng, S. G., Wang, J. H., Koss, M. N., Quismorio, F., Jr., Gray, J. D., Horwitz, D. A., CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 2004. 172: 1531-1539.
7. Scalapino, K. J., Tang, Q., Bluestone, J. A., Bonyhadi, M. L. and Daikh, D. I., Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 2006. 177: 1451-1459.
8. Probst, H. C., McCoy, K., Okazaki, T., Honjo, T. and van den Broek, M., Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 2005. 6: 280-286.
9. Rutella, S., Bonanno, G., Pierelli, L., Mariotti, A., Capoluongo, E., Contemi, A. M., Ameglio, F. et al., Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur. J. Immunol. 2004. 34: 1291-1302.
10. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
11. van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J. and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995. 181: 775-779.
12. von Bergwelt-Baildon, M. S., Popov, A., Saric, T., Chemnitz, J., Classen, S., Stoffel, M. S., Fiore, F. et al., CD25 and indoleamine 2, 3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006. 108: 228-237.
13. Norian, L. A., Rodriguez, P. C., O'Mara, L. A., Zabaleta, J. A., Ochoa, C., Cella, M. and Allen, P. M., Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res. 2009. 69: 3086-3094.
14. Sun, W., Wang, Q., Zhang, L., Liu, Y., Zhang, M., Wang, C., Wang, J. and Cao, X., TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo. J. Mol. Med. 2002. 6: 1351-1359.
15. Wang, Q., Liu, Y., Wang, J., Ding, G., Zhang, W., Chen, G., Zhang, M. et al., Induction of allospecific tolerance by immature dendritic cells genetically modified to express soluble TNF receptor. J. Immunol. 2006. 177: 2175-2185.
16. Zhang, M., Wang, Q., Liu, Y., Sun, Y., Ding, G., Fu, Z., Min, Z. et al., Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival. J. Mol. Med. 2004. 82: 240-249.
17. Kim, S. H., Lechman, E. R., Bianco, N., Menon, R., Keravala, A., Nash, J., Mi, Z. et al., Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 2005. 174: 6440-6448.
18. Kim, S. H., Bianco, N. R., Shufesky, W. J., Morelli, A. E. and Robbins, P. D., Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. J. Immunol. 2007. 179: 2242-2249.
19. Boruchov, A. M., Heller, G., Veri, M. C., Bonvini, E., Ravetch, J. V. and Young, J. W., Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 2005. 115: 2914-2923.
20. Daeron, M., Latour, S., Malbec, O., Espinosa, E., Pina, P., Pasmans, S. and Fridman, W. H., The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995. 3: 635-646.
21. Su, K., Yang, H., Li, X., Li, X., Gibson, A. W., Cafardi, J. M., Zhou, T. et al., Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J. Immunol. 2007. 178: 3272-3780.
22. Mackay, M., Stanevsky, A., Wang, T., Aranow, C., Li, M., Koenig, S., Ravetch, J. V. and Diamond, B., Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J. Exp. Med. 2006. 203: 2157-2164.
23. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J., Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001. 294: 1540-1543.
24. Wu, P., Wu, J., Liu, S., Han, X., Lu, J., Shi, Y., Wang, J. et al., TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin. Immunol. 2008. 129: 40-48.
25. Berkun, Y., Verbovetski, I., Ben-Ami, A., Paran, D., Caspi, D., Krispin, A., Trahtemberg, U. et al., Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur. J. Immunol. 2008. 38: 2896-2904.
26. McGaha, T. L., Sorrentino, B. and Ravetch, J. V., Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 2005. 307: 590-593.
27. Zhang, Y., Liu, S., Liu, J., Zhang, T., Shen, Q., Yu, Y. and Cao, X., Immune complex/Ig negatively regulates TLR4-triggered inflammatory response in macrophages through Fc gammaRIIb-dependent PGE2 production. J. Immunol. 2009. 182: 554-562.
28. Minakuchi, R., Wacholtz, M. C., Davis, L. S. and Lipsky, P. E., Delineation of the mechanism of inhibition of human T cell activation by PGE2. J. Immunol. 1990. 145: 2616-2625.
29. Ahmadi, M., Emery, D. C. and Morgan, D. J., Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. Cancer Res. 2008. 68: 7520-7529.
30. Bryn, T., Yaqub, S., Mahic, M., Henjum, K., Aandahl, E. M. and Taskén, K., LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism. Int. Immunol. 2008. 20: 235-245.
31. Garrone, P., Galibert, L., Rousset, F., Fu, S. M. and Banchereau, J., Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. J. Immunol. 1994. 152: 4282-4290.
32. Splawski, J. B. and Lipsky, P. E., Prostaglandin E2 inhibits T cell-dependent Ig secretion by neonatal but not adult lymphocytes. J. Immunol. 1994. 152: 5259-5267.
33. Krause, P., Bruckner, M., Uermosi, C., Singer, E., Groettrup, M. and Legler, D. F., Prostaglandin E2 enhances T cell proliferation by inducing the co-stimulatory molecules OX40L, CD70 and 4-1BBL on dendritic cells. Blood 2009. 113: 2451-2460.
34. Kaliński, P., Schuitemaker, J. H., Hilkens, C. M. and Kapsenberg, M. L., Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998. 161: 2804-2809.
35. Sá-Nunes, A., Bafica, A., Lucas, D. A., Conrads, T. P., Veenstra, T. D., Andersen, J. F., Mather, T. N. et al., Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J. Immunol. 2007. 179: 1497-1505.